Colorectal cancer is a major cause of morbidity and mortality in the United States; it is the third most common site of cancer in men after prostate and lung cancer, and the second most common site of cancer in women after breast cancer (1) . Furthermore, the incidence of colorectal cancer is increasing in industrial countries (2) . Because familial forms of colon cancer are thought to account for only about 15% of all cases (2) , there is a strong likelihood that both environmental factors and inheritance play important roles in the pathogenesis of this disease.
The National Toxicology Program reported that trihalomethanes, which are by-products of water chlorination, induce colorectal cancers in rats (3) . Epidemiological studies also suggest an association between consumption of chlorination by-products in drinking water and an increased risk for colorectal cancer in humans (4) . Although disinfection of drinking water by chlorination has been a major disease prevention treatment, these findings raise an important public health concern because of the large number of people who consume chlorinated water. In recent years there has been extensive study of the molecular events involved in the development ofhuman colorectal cancer. Consequently, the molecular genetics of colorectal carcinoma are among the best understood of any common human cancer.
To foster an exchange of information and ideas on . . . . . . . . . . . . . . . . . . . . . .   , " b . , . , , , , . ' " ' ' ' $ ' ' " ' ' $ ' ' X ' ' ' ' . . . . . . . . . . . . . . . . . . . . . . . . . . .   ã~. . . . . . . . . . . . . . . . . < . . s . particular the relative roles of the cytochrome P450 isozymes and glutathione-Stransferase. The types and frequencies of mutations induced by these chemicals in critical target genes in colorectal tumors in animal models need to be characterized. There is no evidence at present for a nonmutagenic mechanism in trihalomethaneinduced colorectal cancer.
* Polymorphisms that are involved in either the activation of the chemical (e.g., glutathione-S-transferase and cytochrome P4502E1), the deactivation of mutagenic intermediates, or the control of the disease process (e.g., oncogenes and tumor-suppressor genes) can influence the cancer risk associated with exposure to environmental carcinogens. In addition, the degree of induction of inducible metabolic enzymes can show substantial interindividual variability and environmental factors may influence the expression of various genetic susceptibilities. Thus, genetically susceptible subpopulations should be identified and analyzed separately for their cancer risk.
